U.S. market Closed. Opens in 2 days 56 minutes

CNSP | CNS Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue4.13K11.76K13.07K11.10K1.96KN/A
Gross Profit-4.13K-11.76K-13.07K-11.10K-1.96KN/A
Operating Expenses18.87M15.27M14.03M9.45M3.83M881.79K
Selling, General & Admin4.77M5.97M4.68M4.39M1.98M860.52K
Research & Development14.10M9.30M9.35M5.06M1.85M21.27K
Other Operating ExpensesN/AN/AN/AN/AN/A-6.46M
Operating Income-18.87M-15.27M-14.03M-9.45M-3.83M-881.79K
Other Expenses / Income13.88K-7.03K-9.29K-3.26K-44.23K-6.46M
Before Tax Income-18.85M-15.27M-14.04M-9.46M-3.88M-7.39M
Income Tax Expenses-4.007.03K9.29K3.26K42.28K46.70K
Net Income-18.85M-15.27M-14.50M-9.46M-3.88M-7.39M
Interest Expenses-13.80K7.03K9.29K3.26K44.23K46.70K
Basic Shares Outstanding75.00K27.23K17.00K11.00KN/A439.11K
Diluted Shares Outstanding75.35K27.23K17.57K11.08KN/A439.11K
EBITDA-18.86M-15.26M-14.01M-9.44M-3.83M-7.35M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-18.87M-15.26M-14.48M-9.45M-3.79M-7.30M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙